Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Oseltamivir-resistant influenza viruses get by with a little help from permissive mutations.

Myers JL, Hensley SE.

Expert Rev Anti Infect Ther. 2011 Apr;9(4):385-8. doi: 10.1586/eri.11.2.

2.

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.

Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H; Japanese Influenza Collaborative Study Group.

J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.

PMID:
19962344
3.

Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.

Kiso M, Shinya K, Shimojima M, Takano R, Takahashi K, Katsura H, Kakugawa S, Le MT, Yamashita M, Furuta Y, Ozawa M, Kawaoka Y.

PLoS Pathog. 2010 Aug 26;6(8):e1001079. doi: 10.1371/journal.ppat.1001079.

4.

Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.

Govorkova EA, Ilyushina NA, Marathe BM, McClaren JL, Webster RG.

J Virol. 2010 Aug;84(16):8042-50. doi: 10.1128/JVI.00689-10. Epub 2010 Jun 2.

6.

Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.

Ginting TE, Shinya K, Kyan Y, Makino A, Matsumoto N, Kaneda S, Kawaoka Y.

J Virol. 2012 Jan;86(1):121-7. doi: 10.1128/JVI.06085-11. Epub 2011 Oct 19.

7.

Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.

Guo L, Garten RJ, Foust AS, Sessions WM, Okomo-Adhiambo M, Gubareva LV, Klimov AI, Xu X.

Antiviral Res. 2009 Apr;82(1):29-33. doi: 10.1016/j.antiviral.2009.01.004. Epub 2009 Jan 31.

PMID:
19428592
8.

Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.

Gooskens J, Jonges M, Claas EC, Meijer A, van den Broek PJ, Kroes AM.

JAMA. 2009 Mar 11;301(10):1042-6. doi: 10.1001/jama.2009.297. Epub 2009 Mar 2.

PMID:
19255111
9.

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.

Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV.

Antiviral Res. 2010 Feb;85(2):381-8. doi: 10.1016/j.antiviral.2009.11.005. Epub 2009 Nov 13.

PMID:
19917319
10.

Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.

Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. doi: 10.1128/AAC.00555-08. Epub 2008 Jul 14.

11.

Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal.

Dia N, Niang MN, Diadhiou SA, Goudiaby DG, Faye A, Kiori D, Bâ M, Michel R, Diop OM.

BMC Infect Dis. 2013 Feb 27;13:106. doi: 10.1186/1471-2334-13-106.

12.

Oseltamivir Resistance in Influenza A(H6N2) Caused by an R292K Substitution in Neuraminidase Is Not Maintained in Mallards without Drug Pressure.

Gillman A, Muradrasoli S, Mårdnäs A, Söderström H, Fedorova G, Löwenthal M, Wille M, Daggfeldt A, Järhult JD.

PLoS One. 2015 Sep 30;10(9):e0139415. doi: 10.1371/journal.pone.0139415. eCollection 2015.

13.
14.

Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.

Li L, Li Y, Zhang L, Hou T.

J Chem Inf Model. 2012 Oct 22;52(10):2715-29. doi: 10.1021/ci300375k. Epub 2012 Oct 2.

PMID:
22998323
15.

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA.

J Virol. 2007 Nov;81(22):12418-26. Epub 2007 Sep 12.

16.

Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses.

Butler J, Hooper KA, Petrie S, Lee R, Maurer-Stroh S, Reh L, Guarnaccia T, Baas C, Xue L, Vitesnik S, Leang SK, McVernon J, Kelso A, Barr IG, McCaw JM, Bloom JD, Hurt AC.

PLoS Pathog. 2014 Apr 3;10(4):e1004065. doi: 10.1371/journal.ppat.1004065. eCollection 2014 Apr.

17.

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.

Tashiro M, McKimm-Breschkin JL, Saito T, Klimov A, Macken C, Zambon M, Hayden FG; Neuraminidase Inhibitor Susceptibility Network.

Antivir Ther. 2009;14(6):751-61. doi: 10.3851/IMP1194.

PMID:
19812437
18.
19.

Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.

Yang JR, Huang YP, Chang FY, Hsu LC, Huang HY, Pan YT, Lin YC, Wu HS, Liu MT.

J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.

PMID:
23280715
20.

Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.

Baek YH, Song MS, Lee EY, Kim YI, Kim EH, Park SJ, Park KJ, Kwon HI, Pascua PN, Lim GJ, Kim S, Yoon SW, Kim MH, Webby RJ, Choi YK.

J Virol. 2015 Jan;89(1):287-99. doi: 10.1128/JVI.02485-14. Epub 2014 Oct 15.

Supplemental Content

Support Center